Moolla N, Killick M, Papathanasopoulos M, Capovilla A. Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry. Biochim Biophys Acta. 2016;1860:1854-63 pubmed publisher

Mayer C, Huntenburg J, Nandan A, Schmitt E, Czeloth N, Sparwasser T. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs. J Autoimmun. 2013;47:73-82 pubmed publisher

Toma J, Weinheimer S, Stawiski E, Whitcomb J, Lewis S, Petropoulos C, et al. Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab. J Virol. 2011;85:3872-80 pubmed publisher

Mack C, Tucker R, Sokol R, Karrer F, Kotzin B, Whitington P, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56:79-87 pubmed

Geijtenbeek T, Kwon D, Torensma R, van Vliet S, van Duijnhoven G, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-97 pubmed

Moir S, Lapointe R, Malaspina A, Ostrowski M, Cole C, Chun T, et al. CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. J Virol. 1999;73:7972-80 pubmed